Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-08-27, Stock:NVS, The news for the past five days is as follows:
2020-08-20: NEWS1: FDA approves Novartis Kesimpta® (ofatumumab), the first and only self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis.NEWS2: Influencers with Andy Serwer: Dr. Dan Barouch.
2020-08-21: NEWS1: FDA Nods to Novartis' Kesimpta for Relapsing Forms of MS.NEWS2: Pharma Stock Roundup: SNY, JNJ Acquisition Deals, FDA Approvals.NEWS3:  We need Multiple vaccines to be successful: Dr. Dan Barouch.
2020-08-24: NEWS1: Novartis' Immunotherapy Fails in Late-Stage Skin Cancer Study.NEWS2: Novartis Skin Cancer Drug Combination Involving Spartalizumab Fails Clinical Trial.NEWS3: Novartis CEO says COVID-19 makes valuing takeover targets tougher.NEWS4: Stocks - Europe Seen Higher Amid Virus Treatment Optimism.
2020-08-25: nan
2020-08-26: NEWS1: Novartis push to expand cancer arsenal gets trial win against Pfizer drug.NEWS2: Novartis investigational novel STAMP inhibitor asciminib (ABL001) meets primary endpoint of Phase III chronic myeloid leukemia study.

Answer: Decrease